- Report
- June 2025
- 250 Pages
India
From €2466EUR$2,789USD£2,127GBP
- Report
- June 2025
- 250 Pages
Japan
From €2466EUR$2,789USD£2,127GBP
- Report
- February 2024
- 180 Pages
Global
From €4393EUR$4,969USD£3,790GBP
- Report
- June 2024
- 200 Pages
Global
From €7029EUR$7,950USD£6,064GBP
- Report
- August 2022
- 120 Pages
Global
From €4200EUR$4,750USD£3,623GBP
- Report
- May 2024
- 100 Pages
Africa
From €1768EUR$2,000USD£1,525GBP
- Report
- May 2024
- 80 Pages
China
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
France
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
Germany
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
India
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
Saudi Arabia
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
South Korea
From €1326EUR$1,500USD£1,144GBP
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
United Kingdom
From €1326EUR$1,500USD£1,144GBP
- Report
- May 2024
- 80 Pages
United States
From €1326EUR$1,500USD£1,144GBP
- Report
- September 2024
- 69 Pages
China
From €1592EUR$1,800USD£1,373GBP
- Report
- September 2024
- 227 Pages
China
From €3537EUR$4,000USD£3,051GBP
- Report
- January 2024
- 287 Pages
Global
€4416EUR$4,995USD£3,810GBP
- Report
- July 2023
- 119 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- April 2023
- 107 Pages
Global
From €3500EUR$4,240USD£3,125GBP

The Tuberculosis Drug market is a subset of the larger Respiratory Drug market. It is composed of drugs used to treat tuberculosis, a bacterial infection that affects the lungs and other parts of the body. These drugs are typically antibiotics, such as isoniazid, rifampicin, and ethambutol, and are used in combination to treat the infection. The drugs are usually taken for a period of six to nine months, and are often used in combination with other treatments, such as surgery or chemotherapy.
The Tuberculosis Drug market is highly competitive, with many companies offering different combinations of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Merck, and Novartis. Other companies, such as Cipla, Lupin, and Sun Pharmaceuticals, also offer a range of tuberculosis drugs. Show Less Read more